Advertisement
UK markets closed
  • FTSE 100

    8,139.83
    +60.97 (+0.75%)
     
  • FTSE 250

    19,824.16
    +222.18 (+1.13%)
     
  • AIM

    755.28
    +2.16 (+0.29%)
     
  • GBP/EUR

    1.1679
    +0.0022 (+0.19%)
     
  • GBP/USD

    1.2494
    -0.0017 (-0.13%)
     
  • Bitcoin GBP

    50,337.44
    -1,026.82 (-2.00%)
     
  • CMC Crypto 200

    1,304.48
    -92.06 (-6.59%)
     
  • S&P 500

    5,099.96
    +51.54 (+1.02%)
     
  • DOW

    38,239.66
    +153.86 (+0.40%)
     
  • CRUDE OIL

    83.66
    +0.09 (+0.11%)
     
  • GOLD FUTURES

    2,349.60
    +7.10 (+0.30%)
     
  • NIKKEI 225

    37,934.76
    +306.28 (+0.81%)
     
  • HANG SENG

    17,651.15
    +366.61 (+2.12%)
     
  • DAX

    18,161.01
    +243.73 (+1.36%)
     
  • CAC 40

    8,088.24
    +71.59 (+0.89%)
     

BUZZ-Ahold Delhaize: threatened by fierce Amazon-led competition

** Netherlands-based food retailer shares down 4.2 pct, hitting lowest point in almost 8 mths

** Amazon says to cut prices at Whole Foods starting next week

** Dutch supermarket chain has strong presence on the east coast of the US

** Top ranked analyst* John David Roeg of NIBC says: "The market is saying that competition in the U.S. food retail sector is going to remain fierce for some time to come"

** Retail shares reacted strongly when Amazon acquired Whole Foods

** 4-star analyst* Robert Jan Vos of ABN Amro says their rating on Ahold Delhaize is still "buy"

** Vos reckons Amazon threat may mean digital strategies will be accelerated, but says "Ahold Delhaize is not at all poorly placed to compete"

ADVERTISEMENT

** Co worst performer on pan-European Stoxx 600 and Amsterdam's blue-chip index

** Amazon news dragging down Pan-European retail index (-0.8 pct) with Carrefour (LSE: 0NPH.L - news) shares down 2 pct, Tesco (Swiss: TSCO.SW - news) -1.8 pct, Casino -1.4 pct

(*Analyst rankings from Thomson Reuters StarMine. Scale is from 1-star to 5-star with 5 being best. Analysts ranked on earnings accuracy as well as relative performance of recommendations over trailing 12-month & 24-month periods.)